Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma. [electronic resource]
Producer: 20010920Description: 452-9 p. digitalISSN:- 0815-9319
- Administration, Oral
- Aged
- Antimetabolites, Antineoplastic -- adverse effects
- Carcinoma, Hepatocellular -- drug therapy
- Drug Combinations
- Female
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Prospective Studies
- Survival Analysis
- Tablets, Enteric-Coated
- Tegafur -- adverse effects
- Uracil -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.